Arrowhead Pharmaceuticals
ARWR
#2010
Rank
C$13.76 B
Marketcap
C$98.35
Share price
-1.18%
Change (1 day)
264.00%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2025 (TTM): C-$1.60

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is C-$1.70. In 2024 the company made an earnings per share (EPS) of C-$6.82 a decrease over its 2023 EPS that were of C-$2.61.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$1.60-76.6%
2024C-$6.82161.39%
2023C-$2.6117.36%
2022C-$2.2219.85%
2021C-$1.8561.9%
2020C-$1.15-216.67%
2019C$0.98-210.77%
2018C-$0.8938.3%
2017C-$0.64-64.93%
2016C-$1.83-16.25%
2015C-$2.1828%
2014C-$1.70-3.85%
2013C-$1.77-31.58%
2012C-$2.59331.82%
2011C-$0.60-51.11%
2010C-$1.23-79.07%
2009C-$5.86-37.68%
2008C-$9.41-16.87%
2007C-$11.3238.33%
2006C-$8.18122.22%
2005C-$3.6842.11%
2004C-$2.59533.33%
2003C-$0.41-99.08%
2002C-$44.2625%
2001C-$35.4133.33%
2000C-$26.56-120%
1999C$132.79-400%
1998C-$44.26-81.48%
1997C-$239.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$14.23-935.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
C-$11.00 545.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$3.26-291.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$0.12-107.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
C-$3.93 130.40%๐Ÿ‡บ๐Ÿ‡ธ USA